Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones’ Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson’s Disease
Open Access
- 27 December 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 368
Abstract
Cellular dysfunction during Parkinson’s disease leads to neuroinflammation in various brain regions, inducing neuronal death and contributing to the progression of the disease. Different ion channels may influence the process of neurodegeneration. The peptides Ms 9a-1 and APHC3 can modulate the function of TRPA1 and TRPV1 channels, and we evaluated their cytoprotective effects in differentiated to dopaminergic neuron-like SH-SY5Y cells. We used the stable neuroblastoma cell lines SH-SY5Y, producing wild-type alpha-synuclein and its mutant A53T, which are prone to accumulation of thioflavin-S-positive aggregates. We analyzed the viability of cells, as well as the mRNA expression levels of TRPA1, TRPV1, ASIC1a channels, alpha-synuclein, and tyrosine hydroxylase after differentiation of these cell lines using RT-PCR. Overexpression of alpha-synuclein showed a neuroprotective effect and was accompanied by a reduction of tyrosine hydroxylase expression. A mutant alpha-synuclein A53T significantly increased the expression of the pro-apoptotic protein BAX and made cells more susceptible to apoptosis. Generally, overexpression of alpha-synuclein could be a model for the early stages of PD, while expression of mutant alpha-synuclein A53T mimics a genetic variant of PD. The peptides Ms 9a-1 and APHC3 significantly reduced the susceptibility to apoptosis of all cell lines but differentially influenced the expression of the genes of interest. Therefore, these modulators of TRPA1 and TRPV1 have the potential for the development of new therapeutic agents for neurodegenerative disease treatment.Keywords
Funding Information
- Russian Science Foundation (21-15-00322)
This publication has 52 references indexed in Scilit:
- Polypeptide Modulators of TRPV1 Produce Analgesia without HyperthermiaMarine Drugs, 2013
- Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s DiseaseMediators of Inflammation, 2013
- Neuroprotective efficacy of ABCA1 and HDL in aging rats with cerebrovascular hypoperfusionMolecular Neurodegeneration, 2012
- Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutationTranslational Neurodegeneration, 2012
- Prostaglandin Metabolite Induces Inhibition of TRPA1 and Channel-Dependent NociceptionMolecular Pain, 2012
- α-Synuclein Negatively Regulates Protein Kinase Cδ Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase ActivityThe Journal of Neuroscience, 2011
- Plasma membrane Ca2+-ATPases in the nervous system during development and ageingWorld Journal of Biological Chemistry, 2010
- Diagnosis and treatment of Parkinson disease: molecules to medicineJournal of Clinical Investigation, 2006
- Overexpression of RARγ increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinideCell Death & Differentiation, 2005
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997